Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression med./bio.

By: Patel CB, Beinat C, Xie Y, Chang E, Gambhir SS
Published in: Neoplasia 2021; 23 (1): 58-67
Download citation in RIS format

Exposure